2014-12-25

[DIV28SUPER] NYTimes: Race to Deliver Nicotine=?utf-8?Q?=E2=80=99s_?=Punch, With Less Risk

http://www.nytimes.com/2014/12/25/business/race-to-deliver-nicotines-punch-with-less-risk.html?smprod=nytcore-iphone&smid=nytcore-iphone-share

Big tobacco companies are deploying their financial resources and knowledge in a bid to dominate a potentially huge market for cigarette alternatives.


Sent from my iPhone
___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

2014-12-18

[DIV28SUPER] Invitation to join National Drug Early Warning System (NDEWS) Network listserv

Please see below

---


You are cordially invited to become a part of the new National Drug Early Warning System (NDEWS) Network.

 

NDEWS is a NIDA-funded national public health surveillance system coordinated by the Center for Substance Abuse Research (CESAR) at the University of Maryland, College Park. NDEWS aims to provide the country with critically needed real-time information about changing drug use patterns. The project will focus on new drugs, such as synthetic cannabinoids and designer stimulants, as well as changes in the use of more traditional drugs, such as heroin and methamphetamine. For more information about NDEWS, please visit www.cesar.umd.edu.

 

A key component of NDEWS is the creation of the NDEWS Network, a virtual community of researchers, practitioners, and concerned citizens across the country who will be able to regularly share and discuss information about emerging drugs and changing drug use trends and assist with local NDEWS research. To subscribe to the NDEWS Network electronic mailing list, send an email to listserv@listserv.umd.edu with subscribe ndews-network name-of-subscriber (where name-of-subscriber is your name) in the body of the email. This email should be sent from the email account that will be subscribed to the list.

 

If you know of others who would like to join the NDEWS Network email discussion list, please feel free to forward them this email.

If you have any questions about NDEWS or the NDEWS Network email discussion list, please contact us at ndews@umd.edu.

 

 

NDEWS is funded under NIDA Cooperative Agreement DA038360, awarded to the Center for Substance Abuse Research (CESAR) at the University of Maryland, College Park (UMD). Opinions expressed by participants on the NDEWS Network electronic mailing list may not represent those of CESAR, UMD, or NIDA. CESAR, UMD, and NIDA cannot attest to the accuracy of the statements made by participants of the NDEWS Network electronic mailing list.

 

---
Kelly Dunn, Ph.D.
Assistant Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P: 410-550-2254; F: 410-550-0030

See below

2014-12-17

[DIV28SUPER] Experimental and Clinical Psychopharmacology Special Issue Call for Papers

Please see below for a special issue that may be of interest:


Call for Papers: Experimental and Clinical Psychopharmacology

 

Special Issue for August 2015 on: Sex Differences in Drug Abuse: Etiology and Implications for Prevention and Treatment

 

The goal of this special issue is to broadly highlight how males and females differ in their risks for substance abuse, in their responses to treatments, and in their relapse to substance use after a period of abstinence. Relevant approaches include (but are not limited to) laboratory behavioral, social behavior and environmental context, brain development and function, and the role of genetics, hormones and neuropeptides. Both animal and human methods are appropriate for this issue. Collaborative manuscripts that bridge animal and human findings are especially valued.

 

This special issue is intended to showcase the importance of studying sex differences in drug abuse and how this research might lead to more tailored approaches for prevention and treatment. Laboratories engaged in research in this area may submit review articles or primary research reports to Experimental and Clinical Psychopharmacology to be considered for inclusion in this special issue. Manuscripts should be submitted as usual through the APA Online Submission Portal (www.apa.org/pubs/journals/pha/), and the cover letter should indicate that the authors wish the manuscript to be considered for publication in the special issue on Sex Differences in Drug Abuse.  All submissions will undergo our normal peer review. Manuscripts received no later than March 16, 2015 will be considered for inclusion in the special issue. We strongly encourage individuals to contact us in advance with their ideas and ideally a draft title and abstract.

 

Questions or inquiries about the special issue can be directed to the Guest Editor of the issue, Brady Reynolds, PhD, at brady.reynolds@uky.edu or the Editor, Suzette Evans, PhD at se18@columbia.edu.


               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
Associate Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are
confidential and are intended solely for the addressee. The information
may also be legally privileged. This transmission is sent in trust, for
the sole purpose of delivery to the intended recipient. If you have
received this transmission in error, any use, reproduction or
dissemination of this transmission is strictly prohibited. If you are
not the intended recipient, please immediately notify the sender by
reply e-mail or at (859) 257-5383 and delete this message and its
attachments, if any.

[DIV28SUPER] 13th International Conference on Treatment of Addictive Behaviors

Dear Colleagues;

 

Submissions are due January 25, 2015 for the 13th International Conference on Treatment of Addictive Behaviors (ICTAB-13) to be held in Odense, Denmark (the birthplace of Hans Christian Andersen) from May 31 – June 4, 2015.  Founded in 1979, the ICTAB series brings together clinicians and researchers from the addiction treatment field to explore new science and developments relevant to clinical practice. The theme of ICTAB-13 is “Treating Addictions Where We Find Them:  Healthcare, Mental Health, Social Service, and Criminal Justice Settings”

 

Click here for details about the meeting site, preconference workshops, featured speakers, call for program submissions, and the ICTAB New Investigator Award. 

 

We will be appreciate your spreading the information to your colleagues.

 

Thank you -

 

                                                                                     Barbara

 

Anette Søgaard Nielsen, , Ph.D.                                        Barbara S. McCrady, Ph.D.

Conference Director                                                         Conference Co-Director

ansnielsen@health.sdu.dk                                                bmccrady@unm.edu

+dk 2913 5825                                                               505-925-2388

Psykiatrisk afd. Odense,                                                    Center on Alcoholism, Substance

RESCueH, J.B.                                                                    Abuse and Addictions

Winsløws Vej 20,                                                              University of New Mexico

Indgang 220B, 5000 Odense C                                          2650 Yale Blvd. SE

                                                                                       Albuquerque, NM 87106 USA00

 

2014-12-16

[DIV28SUPER] NYTimes: C.I.A., on Path to Torture, Chose Haste Over Analysis

http://www.nytimes.com/2014/12/16/us/politics/cia-on-path-to-torture-chose-haste-over-analysis-.html?smprod=nytcore-iphone&smid=nytcore-iphone-share

James Mitchell, a former Air Force explosives expert and trainer, and a partner designed, led and directed the interrogations and became the prime advocates for what is now widely considered to have been torture.


Sent from my iPhone
___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

2014-12-14

2014-12-12

2014-12-11

[DIV28SUPER] Collaborative Perspectives on Addiction 2015 - Pre-Conference Workshops Open for Registration!

 

2015 Collaborative Perspectives on Addiction

Reserve Your Hotel | Conference Registration | Call for Proposals

 

Pre-Conference Workshops                    March 6, 2015 8am-12pm

Workshop#1 A Community Support Group Intervention for Substance Users
Presented by Michael Kidorf, PhD,
clinical psychologist and Associate Professor of Psychiatry at Johns Hopkins University School of Medicine.  His work includes the development and evaluation of the Community Support Group Intervention, a clinical strategy designed specifically to activate and expand drug-free social support and reduce drug use.  The Community Support Group Intervention (CSI) is a practical and structured approach for helping substance users activate drug-free social support and expand their recovery-oriented social network.  

 Workshop participants will learn how to: 

§  Identify and activate drug-free people in existing social networks

§  Incorporate CSI within most community-based treatment settings, structure weekly group sessions and assign recovery activities

§  Establish a therapeutic milieu that supports the intervention, identify and successfully manage common problems

Workshop #2 Manualized Cognitive-Behavioral Therapy Group for Diverse Addictive Behaviors

Presented by Bruce Liese, PhD, Professor of Family Medicine and Psychiatry at the University of Kansas Medical Center and Courtesy Professor of Psychology at the University of Kansas.  His work focuses primarily on the development of psychological interventions for treating addictive behaviors and diverse psychological problems.  He has been Director of CBT training for a large multi-center NIDA-funded addictions study and, over time, has supervised hundreds of CB therapists.  This highly interactive workshop presents a manualized cognitive-behavioral therapy addictions group for diverse addictive behaviors, including drug and alcohol misuse, gambling and shopping, binge eating, and pathological Internet use. 
Workshop participants will learn how to: 

§  Explain diverse addictive behaviors (e.g., drug and alcohol misuse, binge eating, problem gambling, Internet addiction) according to a cognitive-behavioral perspective.

§  Describe the structure and essential components of a CBTAG session, including facilitative conditions (e.g., group cohesion) that enhance the effectiveness of the group.

§  Design and implement a CBTAG in their own agency, organization, or community, serving a group of people with diverse addictive behaviors.


Workshop #3 Using Acceptance and Commitment Therapy to Treat Addictive Behaviors     

Presented by Arthur Sandt, PhD, James Finkelstein, PhD, Michele Crisafulli, MA, and Taylor Berens-Crouch, MA.  This workshop will provide an introduction to ACT and its application to addictive behaviors. Theoretical underpinnings, research support, and linkages to other treatment approaches for addictive behaviors will be reviewed. Learning through direct experience will be emphasized through experiential exercises, case examples, demonstrations, and role-plays throughout the workshop.
Workshop participants will learn how to: 

§  Describe the six core processes targeted by ACT and their relevance to individuals with addictive behaviors.

§  Explain similarities and differences between ACT and other empirically-supported approaches to treatment for addictive behaviors (e.g., cognitive behavioral therapy, motivational interviewing, 12-step).

§  Identify how to individually tailor and implement experiential techniques for addictive behaviors in their own clinical work.

 

Workshop Cost:        $75 for Workshops #1, #2, or #3 with conference registration

$115 for Workshops #1, #2, or #3 without conference registration

 

Workshop #4  Free Workshop for Students and Early Career Psychologists -  Post-Bac to Post-Doc: Navigating Graduate School and Beyond

Presented by Sara Jo Nixon, PhD; Jalie Tucker, PhD; Stephen Maisto, PhD; Matthew R. Pearson, PhD; Mark Celio, PhD; David Eddie, MS; and Megan Kirouac, MS.  The goal of this workshop is to provide attendees with valuable advice and guidance about preparing for, and applying to these positions. The seminar will be led by individuals with a track record of success in these areas who will share their personal stories, as well as tips for preparing for and attaining such positions. Following a semi-structured presentation, this workshop will offer separate breakout sessions, with each addressing one of these important career milestones. The panel consists of rising stars in the field of addiction psychology, as well as three senior clinical psychologists with independent research programs who also hold senior academic positions at major research universities. Workshop participants will learn how to: 

§  Identify opportunities and challenges in building a career as an addiction psychologist.

§  Learn how to make, identify, and secure the best CV building opportunities for advancing a   career in addiction psychology.

§  Describe key elements of success in transition from undergraduate to graduate school,   graduate school to internship and/or post doc, and post-doc to early career positions.

 

 

Please register at http://research.alcoholstudies.rutgers.edu/cpa/reg

 

MORE INFORMATION

 

Katie Witkiewitz, PhD, Chair

 

[DIV28SUPER] FW: Call for Applications: 2015-2016 APA Policy Fellowships

--- 

 

Spend a year working on policy in Washington, DC

 

APA’s Congressional and Executive Branch Science Fellowships offer psychologists at all points in their career the opportunity to apply their skills in government

 

APA seeks applications for its Congressional Fellowship and Executive Branch Science Fellowship programs. These opportunities allow a select number of psychologists to spend a year in Washington, D.C., where they receive first-hand experience with federal policymaking and agency research and funding.  Congressional Fellows work as special legislative aides in congressional member or committee offices and engage in a diverse range of policymaking activities on vital issues. One Congressional Fellowship, funded by the American Psychological Foundation, is open to developmental and clinical psychologists with experience working directly with children; the other is open to psychologists working in all areas of the field.  Executive Branch Science Fellows gain crucial experience in science policy and research coordination and funding working in a federal science agency. Both programs offer a year-long stipend and funds to support relocation, travel, and the purchase of health insurance. For more information, visit the program websites or call the Public Interest Government Relations Office at 202.336.5935 or the Science Government Relations office at 202.336.5932.

 


[DIV28SUPER] Learning for Early Careers in Addiction and Diversity (LEAD) Program

Please see below and the attached flyer for information regarding the Learning for Early Careers in Addiction and Diversity (LEAD) Program: 
---
The Learning for Early Careers in Addiction and Diversity (LEAD) Program provides training to early-career research scientists from racial/ethnic minority groups that are underrepresented in the drug abuse research field.  The LEAD Program uses the NIDA Clinical Trials Network (CTN) as a platform for training early stage investigators.  Although based at the University of California, San Francisco (UCSF), visiting scholars accepted to the LEAD program can reside in any city or metropolitan area where a CTN Node is located (see below).  During the 3-year program, scholars will work with a senior mentor at one the CTN Nodes to develop a program of research that will serve as the foundation for receiving independent investigator initiated funding from the National Institutes of Health (NIH).  Scholars will receive temporary visiting academic appointments at UCSF and will spend three summers in a 4-week intensive program in San Francisco.  During the academic year, scholars will work with their primary mentor to collaborate on drug abuse treatment research conducted in the CTN, develop a professional social network, and conduct a pilot study that will serve as a preliminary study for subsequent NIH funding. 

Eligibility Criteria

We are recruiting doctoral-level professionals who are in the early phase of their research careers, and have not yet received a K award or an independent investigator initiated R award from NIH.

The following criteria are preferred: 

1) Doctoral degree (e.g., Ph.D., M.D.) in medicine, social or behavioral sciences, nursing, public health, health economics, or related fields.

2) Assistant professor, assistant research scientist, or equivalent with an academic appointment at a medical school, national research university (i.e., Carnegie Foundation classification as a research university-with high or very high research activity), or research institute.  The institution should have a track record of NIH funding.

3) Racial/ethnic minority background that is underrepresented in the biomedical and behavioral sciences (i.e., African American, Hispanic, American Indian/Alaska Native, Native Hawaiian, or Pacific Islanders).

4) Evidence of an established program of research in the field of drug abuse and addictions as demonstrated by peer reviewed publications in the field of drug abuse and addictions, and/or intramural grant support as either a principal investigator or co-investigator, and/or extramural grant support as a co-investigator. (Candidates who were a principal investigator on a K award, R03, R21, R01, or a component leader of a center grant will not be considered.)

5) Reside in the same city or metropolitan area where a NIDA Clinical Trials Network (CTN) Node is located (For a list of CTN Nodes and locations see http://www.drugabuse.gov/about-nida/organization/cctn/ctn/network-organization/nodes).

Selection & How to Apply

Selection will be based on the following factors: 

* Academic training and achievement during graduate and post graduate academic careers


* Strength of letters of recommendation, fit with the goals of the LEAD Program, and the match between a prospective candidate's research interests and the research interests of the potential mentor at one of the universities affiliated with a NIDA Clinical Trails Network (CTN) Node

To apply, please contact Diane Coseo at diane.coseo@ucsf.edu, or (415) 206-3051 for an application packet.



2014-12-10

[DIV28SUPER] Tests to measure alcohol consumption

Dear Colleagues,

As a follow-up to the questions that I asked yesterday, I would like also to ask for suggestions for tests of alcohol consumption to use to evaluate treatment outcome.

The study involves using neurofeedback training as an add-on (or not) for patients who have undergone detoxification and are having outpatient treatment with alcohol counsellors. Thus, I am looking for a relatively simple (but, of course, valid and reliable) measure of alcohol consumption to use at various points following the intervention.

Thank you very much.

Best wishes,

Miles Cox

W. Miles Cox, Ph.D., CPsychol, FAPA, FAPS, FBPsS
Professor of Psychology
Bangor University
Bangor, Gwynedd LL572AS
UNITED KINGDOM
________________________________________
From: W. Miles Cox
Sent: 09 December 2014 15:32
To: DIV50ANNOUNCE@lists.apa.org; DIV28SUPER@lists.apa.org
Subject: Alcohol Consumption Outcome Measures

Dear Colleagues,

I would greatly appreciate any information about the following points:

Following abstinence-oriented treatment for alcohol dependence, what outcome measures of alcohol consumption are best to use? I am interested in both binary ("relapsed" or not) and continuous (quantity and frequency of drinking) outcome measures. In the case of a binary outcome, how should "relapse" be defined?

Searching PsycINFO, I have not been able to locate a good article that addresses these issues. Thus, I would also appreciate relevant references.

Thank you very much.

Best wishes,

Miles Cox

W. Miles Cox, Ph.D., CPsychol, FAPA, FAPS, FBPsS
Professor of Psychology
Bangor University
Bangor, Gwynedd LL572AS
UNITED KINGDOM


Rhif Elusen Gofrestredig 1141565 - Registered Charity No. 1141565

Mae'r e-bost yma'n amodol ar delerau ac amodau ymwadiad e-bost Prifysgol Bangor. Gellir darllen testun llawn yr ymwadiad yma.<http://www.bangor.ac.uk/emaildisclaimer>

This email is subject to the terms and conditions of the Bangor University email disclaimer. The full text of the disclaimer can be read here<http://www.bangor.ac.uk/emaildisclaimer>



Rhif Elusen Gofrestredig 1141565 - Registered Charity No. 1141565

Gall y neges e-bost hon, ac unrhyw atodiadau a anfonwyd gyda hi, gynnwys deunydd cyfrinachol ac wedi eu bwriadu i'w defnyddio'n unig gan y sawl y cawsant eu cyfeirio ato (atynt). Os ydych wedi derbyn y neges e-bost hon trwy gamgymeriad, rhowch wybod i'r anfonwr ar unwaith a dilewch y neges. Os na fwriadwyd anfon y neges atoch chi, rhaid i chi beidio a defnyddio, cadw neu ddatgelu unrhyw wybodaeth a gynhwysir ynddi. Mae unrhyw farn neu safbwynt yn eiddo i'r sawl a'i hanfonodd yn unig ac nid yw o anghenraid yn cynrychioli barn Prifysgol Bangor. Nid yw Prifysgol Bangor yn gwarantu bod y neges e-bost hon neu unrhyw atodiadau yn rhydd rhag firysau neu 100% yn ddiogel. Oni bai fod hyn wedi ei ddatgan yn uniongyrchol yn nhestun yr e-bost, nid bwriad y neges e-bost hon yw ffurfio contract rhwymol - mae rhestr o lofnodwyr awdurdodedig ar gael o Swyddfa Cyllid Prifysgol Bangor.

This email and any attachments may contain confidential material and is solely for the use of the intended recipient(s). If you have received this email in error, please notify the sender immediately and delete this email. If you are not the intended recipient(s), you must not use, retain or disclose any information contained in this email. Any views or opinions are solely those of the sender and do not necessarily represent those of Bangor University. Bangor University does not guarantee that this email or any attachments are free from viruses or 100% secure. Unless expressly stated in the body of the text of the email, this email is not intended to form a binding contract - a list of authorised signatories is available from the Bangor University Finance Office.

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

2014-12-09

[DIV28SUPER] 63rd Annual NE Symposium

63rd Annual Nebraska
Symposium on Motivation
University of Nebraska–Lincoln Department of Psychology
APRIL 9-10, 2015
​Free and open to the public


This two-day symposium will generate an integrated understanding of the
neurobiological and psychological processes that lead to the disabling
condition known as “schizophrenia,” including revolutionary ideas about the basic nature of mental illness.

SPEAKERS
William Carpenter, M.D., University of Maryland
Bruce Cuthbert, National Institute of Mental Health
Raquel Gur, Ph.D., University of Pennsylvania
Ruben Gur, Ph.D., University of Pennsylvania
David Lewis, M.D., University of Pittsburgh
Steven Silverstein, Ph.D., Rutgers University


Re: [DIV28SUPER] Alcohol Consumption Outcome Measures

I have used the Daily Drinking Questionnaire (DDQ) in the past for frequency and amount. In regards to relapse, clinical use of the term (in abstinence models) typically is associated with any alcohol or drug use. Marlatt's model has a definition for relapse but it also includes a "lapse" which might be something of interest if you're not strictly looking for a binary coded outcome. A quick search resulted in this piece from NIH (http://pubs.niaaa.nih.gov/publications/arh23-2/151-160.pdf). Hope this helps.

--
Philip J. Uy, Ph.D., LMFT
Psychologist (MI# 6301015674; NY #020267)
Marriage and Family Therapist (NY #
000681)
National Provider Identifier (NPI) #1831331610

------------------------------------------------------------
This email message, including any attachments, is for the sole use of the intended recipient(s) and may contain information that is proprietary, confidential, and exempt from disclosure under applicable law. Any unauthorized review, use, disclosure, or distribution is prohibited. If you have received this email in error please notify the sender by return email and delete the original message. Please note, the recipient should check this email and any attachments for the presence of viruses. The organization accepts no liability for any damage caused by any virus transmitted by this email.
=================================

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

Re: [DIV28SUPER] Alcohol Consumption Outcome Measures

Miles: have you done a search of PsycTESTS, the measurement instrument database? Gary



Sent from my iPhone

> On Dec 9, 2014, at 10:43 AM, "W. Miles Cox" <m.cox@BANGOR.AC.UK> wrote:
>
> Dear Colleagues,
>
> I would greatly appreciate any information about the following points:
>
> Following abstinence-oriented treatment for alcohol dependence, what outcome measures of alcohol consumption are best to use? I am interested in both binary ("relapsed" or not) and continuous (quantity and frequency of drinking) outcome measures. In the case of a binary outcome, how should "relapse" be defined?
>
> Searching PsycINFO, I have not been able to locate a good article that addresses these issues. Thus, I would also appreciate relevant references.
>
> Thank you very much.
>
> Best wishes,
>
> Miles Cox
>
> W. Miles Cox, Ph.D., CPsychol, FAPA, FAPS, FBPsS
> Professor of Psychology
> Bangor University
> Bangor, Gwynedd LL572AS
> UNITED KINGDOM
>
>
> Rhif Elusen Gofrestredig 1141565 - Registered Charity No. 1141565
>
> Gall y neges e-bost hon, ac unrhyw atodiadau a anfonwyd gyda hi, gynnwys deunydd cyfrinachol ac wedi eu bwriadu i'w defnyddio'n unig gan y sawl y cawsant eu cyfeirio ato (atynt). Os ydych wedi derbyn y neges e-bost hon trwy gamgymeriad, rhowch wybod i'r anfonwr ar unwaith a dilewch y neges. Os na fwriadwyd anfon y neges atoch chi, rhaid i chi beidio a defnyddio, cadw neu ddatgelu unrhyw wybodaeth a gynhwysir ynddi. Mae unrhyw farn neu safbwynt yn eiddo i'r sawl a'i hanfonodd yn unig ac nid yw o anghenraid yn cynrychioli barn Prifysgol Bangor. Nid yw Prifysgol Bangor yn gwarantu bod y neges e-bost hon neu unrhyw atodiadau yn rhydd rhag firysau neu 100% yn ddiogel. Oni bai fod hyn wedi ei ddatgan yn uniongyrchol yn nhestun yr e-bost, nid bwriad y neges e-bost hon yw ffurfio contract rhwymol - mae rhestr o lofnodwyr awdurdodedig ar gael o Swyddfa Cyllid Prifysgol Bangor.
>
> This email and any attachments may contain confidential material and is solely for the use of the intended recipient(s). If you have received this email in error, please notify the sender immediately and delete this email. If you are not the intended recipient(s), you must not use, retain or disclose any information contained in this email. Any views or opinions are solely those of the sender and do not necessarily represent those of Bangor University. Bangor University does not guarantee that this email or any attachments are free from viruses or 100% secure. Unless expressly stated in the body of the text of the email, this email is not intended to form a binding contract - a list of authorised signatories is available from the Bangor University Finance Office.
>
> ___________________ div28SUPER@lists.apa.org _____________________
> Div28m members may post here subscribers corner: http://lists.apa.org

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

[DIV28SUPER] NIDA Women and Sex/Gender Differences Junior Investigator Travel Award Program at CPDD -- Deadline for Submissions Extended to January 16, 2015 --

 

NIDA Women and Sex/Gender Differences Junior Investigator

Travel Award Program at CPDD 2015

Deadline for Submission Extended to January 16, 2015

Accumulating research, both human and animal, finds that the antecedents, consequences and mechanisms of drug abuse and dependence often differ between males and females.  Such differences may affect responses to treatment and prevention.  To help promote comparisons of outcomes in males and females and to promote female-specific research, NIDA plans to provide $750 travel awards to 27 junior investigators who present their research on women or sex/gender analyses in any area of drug abuse at the annual meeting of the College on Problems of Drug Dependence (CPDD) in Phoenix, AZ, June 13-18, 2015.

 

Travel award recipients must be the first author on their accepted oral presentation or poster.  Eligible applicants include graduate and medical students, postdocs, medical residents and researchers who are no more than five years past earning their doctoral degree or finishing their residency.  NIDA encourages male and minority investigators to apply.

 

Applications are now due by Friday January 16, 2015.  Full eligibility and submission requirements can be found by clicking here and by contacting Dr. Samia Noursi (snoursi@mail.nih.gov; 301-594-5622) or Dr. Cora Lee Wetherington (wetherington@nih.gov; 301-435-1319).

 

 

 

 

 

_______________________________________________________________________________________________

Samia Dawud Noursi, Ph.D.

Deputy Coordinator - Women and Sex/Gender Differences Research Program

National Institute on Drug Abuse (NIDA)

National Institutes of Health (NIH)

6001 Executive Blvd., Suite 3155, MSC 9593

Bethesda, Maryland 20892-9555

(for overnight mail: Rockville, MD 20857)

Phone: 301-594-5622

E-mail: snoursi@mail.nih.gov

Fax 301-443-6814

 

 

[DIV28SUPER] Alcohol Consumption Outcome Measures

Dear Colleagues,

I would greatly appreciate any information about the following points:

Following abstinence-oriented treatment for alcohol dependence, what outcome measures of alcohol consumption are best to use? I am interested in both binary ("relapsed" or not) and continuous (quantity and frequency of drinking) outcome measures. In the case of a binary outcome, how should "relapse" be defined?

Searching PsycINFO, I have not been able to locate a good article that addresses these issues. Thus, I would also appreciate relevant references.

Thank you very much.

Best wishes,

Miles Cox

W. Miles Cox, Ph.D., CPsychol, FAPA, FAPS, FBPsS
Professor of Psychology
Bangor University
Bangor, Gwynedd LL572AS
UNITED KINGDOM


Rhif Elusen Gofrestredig 1141565 - Registered Charity No. 1141565

Gall y neges e-bost hon, ac unrhyw atodiadau a anfonwyd gyda hi, gynnwys deunydd cyfrinachol ac wedi eu bwriadu i'w defnyddio'n unig gan y sawl y cawsant eu cyfeirio ato (atynt). Os ydych wedi derbyn y neges e-bost hon trwy gamgymeriad, rhowch wybod i'r anfonwr ar unwaith a dilewch y neges. Os na fwriadwyd anfon y neges atoch chi, rhaid i chi beidio a defnyddio, cadw neu ddatgelu unrhyw wybodaeth a gynhwysir ynddi. Mae unrhyw farn neu safbwynt yn eiddo i'r sawl a'i hanfonodd yn unig ac nid yw o anghenraid yn cynrychioli barn Prifysgol Bangor. Nid yw Prifysgol Bangor yn gwarantu bod y neges e-bost hon neu unrhyw atodiadau yn rhydd rhag firysau neu 100% yn ddiogel. Oni bai fod hyn wedi ei ddatgan yn uniongyrchol yn nhestun yr e-bost, nid bwriad y neges e-bost hon yw ffurfio contract rhwymol - mae rhestr o lofnodwyr awdurdodedig ar gael o Swyddfa Cyllid Prifysgol Bangor.

This email and any attachments may contain confidential material and is solely for the use of the intended recipient(s). If you have received this email in error, please notify the sender immediately and delete this email. If you are not the intended recipient(s), you must not use, retain or disclose any information contained in this email. Any views or opinions are solely those of the sender and do not necessarily represent those of Bangor University. Bangor University does not guarantee that this email or any attachments are free from viruses or 100% secure. Unless expressly stated in the body of the text of the email, this email is not intended to form a binding contract - a list of authorised signatories is available from the Bangor University Finance Office.

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

2014-12-07

[DIV28SUPER] NIDA Neuroscience Update Dec 8, 2014

Table of Contents

 

I.          The RRID: An easy way to make methods sections better. 

II.          Request for Information (RFI): Challenges and Opportunities for Exploring and Understanding the Epitranscriptome NOT-RM-15-007
NIH Roadmap Initiatives.

III.         BRAIN Initiative: Development and Validation of Novel Tools to Analyze Cell-Specific and Circuit Specific Processes in the Brain (U01)  RFA-MH-15-225 

IV.        BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (U01) RFA-NS-15-003

V.         BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01)   RFA-NS-15-004 

VI.        4D Nucleome Imaging Tools (U01) RFA-RM-14-007

VII.       Extracellular Vesicles in HIV/AIDS and Substance Abuse (R21 RFA-DA-15-012  and  (R01) RFA-DA-15-011

VIII.       Prize Competition: Challenges in Single Cell Analysis NOT-RM-14-014

XI.      Administrative Supplement for Research on Sex/Gender Differences  PA-15-034

 

 

 

I. The RRID: An easy way to make methods sections better. 

 

Arguments about research reproducibility continue (Nature has a special issue on this topic), but nobody would argue that better identification of research resources, the most basic tools of science e.g., antibodies, organisms or software tools, is a bad idea. The RII group (force11.org/node/4463, which includes partners such as J.Neurosci, JCN, etc.) helps authors identify research resources without ambiguity and we would love to throw our support behind this effort. For authors it is as easy as going to http://scicrun.ch/resources, searching for your resource, copying the "cite this" text and pasting it in your methods. The resource reference should look like this: NeuN antibody, Millipore Cat# MAB377, RRID:AB_2298772. If enough people do this, we can ask PubMed Central or google scholar "who is using my antibody and under what conditions?" For the NeuN antibody and common software tools this is possible now, see: 

http://scholar.google.com/scholar?q=RRID%3AAB_90755

http://scholar.google.com/scholar?q=RRID%3Anif-0000-30467

http://scholar.google.com/scholar?q=RRID%3Arid_000042

 

II. Request for Information (RFI): Challenges and Opportunities for Exploring and Understanding the Epitranscriptome (NOT-RM-15-007)
NIH Roadmap Initiatives.
Please respond by January 10, 2015

The purpose of this Request for Information (RFI) is to solicit feedback from the community on the scientific challenges, opportunities, and tool/technology needs in the area of RNA chemical modifications (sometimes referred to as epitranscriptomics), with the ultimate goal of accelerating our understanding of the roles of RNA modifications in human health, development and disease.

 

 

III. BRAIN Initiative: Development and Validation of Novel Tools to Analyze Cell-Specific and Circuit Specific Processes in the Brain (U01)  RFA-MH-15-225 

Applications due March 18, 2015, by 5:00 PM

 

The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is to encourage applications that will develop and validate novel tools to facilitate the detailed analysis of complex circuits and provide insights into cellular interactions that underlie brain function. The new tools and technologies should inform and/or exploit cell-type and/or circuit-level specificity. Plans for validating the utility of the tool/technology will be an essential feature of a successful application. The development of new genetic and non-genetic tools for delivering genes, proteins and chemicals to cells of interest or approaches that are expected to target specific cell types and/or circuits in the nervous system with greater precision and sensitivity than currently established methods are encouraged. Tools that can be used in a number of species / model organisms rather than those restricted to a single species are highly desired. Applications that provide approaches that break through existing technical barriers to substantially improve current capabilities are highly encouraged.

 

 

IV. BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (U01) RFA-NS-15-003

Application due date:  February 10, 2015, by 5:00 PM local time of applicant organization

 

Understanding the dynamic activity of neural circuits is central to the NIH BRAIN Initiative. This FOA seeks applications for proof-of-concept testing and development of new technologies and novel approaches for large scale recording and manipulation of neural activity, to enable transformative understanding of dynamic signaling in the nervous system. In particular we seek exceptionally creative approaches to address major challenges associated with recording and manipulating neural activity, at or near cellular resolution, at multiple spatial and/or temporal scales, in any region and throughout the entire depth of the brain. It is expected that the proposed research may be high risk, but if successful could profoundly change the course of neuroscience research.

 

Proposed technologies should be compatible with experiments in behaving animals, and should include advancements that enable or reduce major barriers to hypothesis-driven experiments. Technologies may engage diverse types of signaling beyond neuronal electrical activity for large-scale analysis, and may utilize any modality such as optical, electrical, magnetic, acoustic or genetic recording/manipulation. Applications that seek to integrate multiple approaches are encouraged. Where appropriate, applications are expected to integrate appropriate domains of expertise, including biological, chemical and physical sciences, engineering, computational modeling and statistical analysis.

 

 

V. BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01)   RFA-NS-15-004 

Application due date: February 10, 2015, by 5:00 PM local time of applicant organization.

 

Although invention and proof-of-concept testing of new technologies are key components of the BRAIN Initiative, to achieve their potential these technologies must also be optimized through feedback from end-users in the context of the intended experimental use. In this FOA we seek applications for thoptimization of existing and emerging technologies and approaches that have potential to address major challenges associated with recording and manipulating neural activity, at or near cellular resolution, at multiple spatial and temporal scales, in any region and throughout the entire depth of the brain. This FOA is intended for the iterative refinement of emergent technologies and approaches that have already demonstrated their transformative potential through initial proof-of-concept testing, and are appropriate for accelerated development of hardware and software while scaling manufacturing techniques towards sustainable, broad dissemination and user-friendly incorporation into regular neuroscience practice.

 

Proposed technologies should be compatible with experiments in behaving animals, and should include advancements that enable or reduce major barriers to hypothesis-driven experiments. Technologies may engage diverse types of signaling beyond neuronal electrical activity for large-scale analysis, and may utilize any modality such as optical, electrical, magnetic, acoustic or genetic recording/manipulation. Applications that seek to integrate multiple approaches are encouraged. Applications are expected to apply expertise that integrates appropriate domains of expertise, including where appropriate biological, chemical and physical sciences, engineering, computational modeling and statistical analysis.

 

 

VI. 4D Nucleome Imaging Tools (U01) RFA-RM-14-007

Application due date:  February 2, 2015

 

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications that propose to develop and validate physical, chemical and biochemical approaches for measuring properties and dynamics of the three-dimensional organization of the genome that cannot be measured adequately using existing methodologies.

 

VII. Extracellular Vesicles in HIV/AIDS and Substance Abuse (R21)  RFA-DA-15-012  and  (R01) RFA-DA-15-011 

The purpose of this FOA is to encourage research projects that investigate extracellular vesicles in HIV infection/progression or as potential HIV/AIDS biomarkers or therapeutics.  Proposed projects must also explore the potential impact of exposure to substances of abuse.



VIII. Prize Competition: Challenges in Single Cell Analysis NOT-RM-14-014

The NIH Common Fund Single Cell Analysis Program is seeking novel robust methods for analysis of individual cells that can detect and assess changes in cell behavior and function over time either as a result of natural state changes or when perturbed (e.g., by a drug, biological stimulus, infectious agent, pathological lesion, or mechanical forces).  It is hoped that such methods will yield creative and new, yet feasible, solutions for following a single cell over time in a complex multicellular environment to detect changing cell properties, preferably using multiple integrated measures.

Please direct all inquiries to:

Yong Yao, Ph.D.
NIH Common Fund
National Institute of Mental Health (NIMH)
Telephone: 301-443-6102
Email: Yong.Yao@nih.gov


 

XI. "Administrative Supplement for Research on Sex/Gender Differences," PA-15-034   Application Deadline:  January 12, 2015 by 5:00 PM local time of applicant organization.

 

The NIH Office of Research on Women's Health (ORWH) again announces the availability of 1-year administrative supplements up to $100,000 in total costs to support research highlighting the impact of sex/gender differences (or similarities) and/or sex and gender factors in human health and illness, including basic, preclinical, clinical and behavioral studies.  Of special interest are studies relevant to understanding of the significance of biological sex on cells; comparative studies of male and female tissues, organ systems and physiological systems; sex based comparisons of pathophysiology, biomarkers, gene expression, clinical presentation and prevention and treatment of diseases.  Whereas in FY14 the ORWH set aside was $5 million for 50 supplements, for FY 15

 

------------------

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov     301-435-1309

 

2014-12-05

[DIV28M] Call for Nominations- Division 28 Awards

Dear Colleagues:  I am writing to encourage you to submit nomination materials for APA Division 28 Awards for the 2015 APA meeting in Toronto.  Attached you will find the official call for nominations with the detailed instructions for each of the three awards:  Med Associates Brady-Schuster Award, Young Psychopharmacologist Award and Outstanding Dissertation Award.  These awards are an excellent way to recognize your outstanding colleagues in science- both the young and more seasoned!  The Awards Committee looks forward to seeing this year's nominees.  The deadline for materials is January 15, 2015.  

Regards,
Sharon

--
Dr. Sharon L. Walsh
Provost's Distinguished Service Professor
Center on Drug and Alcohol Research
Department of Behavioral Science
University of Kentucky
Lab Phone:  859-257-6485
Fax: 859-257-5232

2014-12-01

[DIV28_ANNOUNCEMENT] Division 28 newsletter

Attached is the final issue of the 2014 APA Division 28 newsletter.

 

Enjoy,

Micky Koffarnus

 

 

Mikhail Koffarnus

Research Assistant Professor

Virginia Tech Carilion Research Institute

2 Riverside Circle

Roanoke, VA 24016

phone: 540.526.2107

 

2014-11-25

[DIV28M] 2015 APA Convention Call for Submissions

Dear Division 28 Members-

 

                The December 1st submission deadline for the 2015 APA Convention in Toronto (August 6-9) is quickly approaching.  The division leadership would like to encourage symposia that involve both senior and junior scientists because one of the presidential initiatives for 2015 is to increase intergenerational collaboration and communication within Division 28.  Individual submissions are encouraged as well.

The highly successful NIDA/NIAAA Early Career Investigators Poster Session and Social Hour will again occur this year!  There will be travel funding opportunities for early career (e.g., students, postdocs, new to the field) and diversity candidates.  There will also be special consideration for local participants.  The session is open to all, and we encourage strong early career, diversity, and local applicants. 

 

Cheers,

Matt

 

 

                                                                                        

Matthew T. Weaver, Ph.D.

Assistant Professor                                                

Department of Psychology

Mercyhurst University

501 East 38th St.

Erie, PA 16546

Phone: 814.824.2733

Email: mweaver@mercyhurst.edu

P Please consider the environment before printing this correspondence.

 

Statement of Confidentiality:

The contents of this e-mail message and any attachments are confidential and are intended solely for addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If are not the intended addressee or you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or phone and delete this message and its attachments, if any.

888888888888888888888888888888888888888888888888888888888888888888

This electronic message and its attachments, if any, are from Mercyhurst University and may include information that is confidential and may be protected under federal and/or state law. This information is intended solely for the addressee only. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution or action taken in reliance on the contents of this message is strictly prohibited. If you have received this email in error, please notify the sender immediately by replying to this message and deleting the material from any computer so received.

888888888888888888888888888888888888888888888888888888888888888888